Vitrakvi
List of products in the National Drug Code with proprietary name vitrakvi. Larotrectinib is used to treat cancer. It works by slowing or stopping the growth of cancer cells.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
50419-390 | Vitrakvi | Larotrectinib | Capsule | Oral | Bayer Healthcare Pharmaceuticals Inc. | Human Prescription Drug |
50419-391 | Vitrakvi | Larotrectinib | Capsule | Oral | Bayer Healthcare Pharmaceuticals Inc. | Human Prescription Drug |
50419-392 | Vitrakvi | Larotrectinib | Solution, Concentrate | Oropharyngeal | Bayer Healthcare Pharmaceuticals Inc. | Human Prescription Drug |
50419-393 | Vitrakvi | Larotrectinib | Solution, Concentrate | Oropharyngeal | Bayer Healthcare Pharmaceuticals Inc. | Human Prescription Drug |
71777-390 | Vitrakvi | Larotrectinib | Capsule | Oral | Loxo Oncology, Inc. | Human Prescription Drug |
71777-391 | Vitrakvi | Larotrectinib | Capsule | Oral | Loxo Oncology, Inc. | Human Prescription Drug |
71777-392 | Vitrakvi | Larotrectinib | Solution | Oral | Loxo Oncology, Inc. | Human Prescription Drug |